Skip to content

A study for the safety andeffecacy of tissue engineering skin in the treatment diabetic foot (the repair period)

A study for the safety andeffecacy of tissue engineering skin in the treatment diabetic foot (the repair period)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002509
Enrollment
Unknown
Registered
2012-09-11
Start date
2009-05-04
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot

Interventions

Experimental:Tissue enginering skin for 12 weeks

Sponsors

The General Hospital of China Air Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18~75 years; 2. To be attend the trial voluntary andsigned the informed consent; 3. Who with the diabetic foot (the repair period); 4. The blood sugar to be controlled well (fast blood sugar level should be lower that 8 mmol/L).

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation woman; 2. The wound area to be with fistula, or infection; 3. ALT andAST volues higner two folders than normal level; 4. To be abnormal on renal function (Cr); 5. To be with severe cardiovascular or cerebral vascular disease; 6. To be with malnutrition such as Hypoproteinemia, etc.; 7. To be with blood system disease; 8. To be with immune system disease; 9. To be with severe skin disease; 10. To be with tumour; 11. To be attended other clinical trial with past three monthes.

Design outcomes

Primary

MeasureTime frame
Change of the wound face size;Recovery time of the wound face;Rate of recovery;

Secondary

MeasureTime frame
The status of the pigmentation and scar;

Countries

China

Contacts

Public ContactGuan Xiaohong
baojunli319@yahoo.com.cn+86 15611161115

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026